Search for Stocks /

Diamines & Chemicals Q3 FY26: Sales Crash 56%, PAT –₹3.40 Cr, OPM –37% — Is India’s Sole Ethylene Amine Maker Losing Its Chemical Reaction?


1. At a Glance – The Chemical That Forgot to React

Smallcap alert. Market cap ₹238 Cr. Current price ₹244. Down 17.5% in 3 months and 36.2% in one year. Sales down 56.4% YoY this quarter. PAT? Negative ₹3.40 Cr. Operating margin? A dramatic –37.43%.

Welcome to Diamines & Chemicals Ltd, India’s sole manufacturer of ethylene amines, currently demonstrating what happens when chemistry and profitability stop bonding.

ROCE stands at 3.33%. ROE at 1.78%. EPS (TTM) at –₹9.30. Debt-to-equity is a tiny 0.06 (almost debt free), but interest coverage is –29.2 because… well… there’s no operating profit to cover interest.

High was ₹458. Low ₹227. Stock currently chilling near the lower end like a student who peaked in 2021 and hasn’t recovered since.

The real question: Is this a temporary cyclical downturn in specialty chemicals… or is this smallcap slowly evaporating?

Let’s put on our detective hat. 🕵️♂️


2. Introduction – When a Chemical Giant Feels Like a Lab Experiment

Founded in 1976, Diamines & Chemicals has survived license raj, liberalization, global recessions, and three generations of Mehtas running the show.

For years, it proudly held the badge of being India’s only ethylene amine manufacturer. That’s not a small title. Ethylene amines are critical intermediates used in pharmaceuticals, agrochemicals, water treatment, gas sweetening, polyamide resins, and more.

Basically, if chemistry is cooking, they supply the masala.

But FY25 and FY26 so far? The masala is burning.

Revenue has shrunk. Margins have collapsed. Inventory days have ballooned. Working capital days jumped from 125 to 185. OPM has gone from a majestic 50% in FY23 to negative territory.

This is no longer just “cyclical weakness.” This is what happens when demand slows, realizations drop, and fixed costs sit there like uninvited wedding guests.

You're reading a premium analysis. Continue reading →
You've used all 2 free articles in this window. Join 10,000+ members for unlimited access.
Become a member
Already a member? Log in
You're reading a premium analysis. Continue reading →